Elevated levels of systemic inflammatory biomarkers, including interleukins (ILs), tumor necrosis factor (TNF), interferon (IFN), and procalcitonin (PCT), have been identified in patients with epilepsy (8–14). This evidence concerns the gene TNF and epilepsy.